Suppr超能文献

2006年和2024年1至59岁人群乙肝疫苗接种率及表面抗体阳性率调查

Survey of Hepatitis B Vaccination Coverage and Surface Antibody-Positive Rates in People Aged 1-59 Years in 2006 and 2024.

作者信息

Gong Xiaoying, Zheng Canjie, Fang Quanjun, Xu Wenjie, Yin Zhiying

机构信息

Department of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.

出版信息

Open Forum Infect Dis. 2024 Oct 5;11(10):ofae589. doi: 10.1093/ofid/ofae589. eCollection 2024 Oct.

Abstract

BACKGROUND

Implementing hepatitis B vaccination is an important strategy to reduce hepatitis B virus infection and disease burden. Suboptimal adult hepatitis B vaccination coverage limits the further reduction of hepatitis B virus infection.

METHODS

A multistage stratified random sampling method was adopted to survey the permanent population aged 1-59 in 2006 and 2024. We calculated the vaccination coverage rate, hepatitis B surface antibody (HBsAb)-positive rate, rate difference, and their 95% confidence intervals (CIs) of the 2 survey populations, and used the 95% CI and χ test to determine whether the difference in rate was statistically significant.

RESULTS

Six hundred twenty-three people were surveyed in 2006 and 606 people were surveyed in 2024. From 2006 to 2024, the hepatitis B vaccination coverage among people aged 1-59 years increased from 54.1% to 78.9%, and the HBsAb-positive rate increased from 46.2% to 57.6%. There was no significant difference in vaccination coverage in the population <15 years of age, but the antibody-positive rate increased significantly. The vaccination coverage rate of the 15-59 age group increased significantly, but there was no statistical difference in the antibody positivity rate of the 15-49 age group, and the antibody positivity rate of the 50-59 age group increased significantly.

CONCLUSIONS

Hepatitis B vaccination coverage among adults was still insufficient. Hepatitis B vaccine-mediated immunity was low in adults aged 30-49 years. It is recommended to update the guidelines for hepatitis B vaccination of adults in China, cancel the assessment of risk factors and prevaccination serological screening, and emphasize universal vaccination of all unvaccinated adults to increase coverage.

摘要

背景

实施乙肝疫苗接种是降低乙肝病毒感染和疾病负担的重要策略。成人乙肝疫苗接种覆盖率不理想限制了乙肝病毒感染的进一步降低。

方法

采用多阶段分层随机抽样方法,对2006年和2024年1至59岁常住人口进行调查。计算两个调查人群的疫苗接种覆盖率、乙肝表面抗体(HBsAb)阳性率、率差及其95%置信区间(CIs),并使用95%CI和χ检验确定率的差异是否具有统计学意义。

结果

2006年调查623人,2024年调查606人。2006年至2024年,1至59岁人群的乙肝疫苗接种覆盖率从54.1%提高到78.9%,HBsAb阳性率从46.2%提高到57.6%。15岁以下人群的疫苗接种覆盖率无显著差异,但抗体阳性率显著提高。15至59岁年龄组的疫苗接种覆盖率显著提高,但15至49岁年龄组的抗体阳性率无统计学差异,50至59岁年龄组的抗体阳性率显著提高。

结论

成人乙肝疫苗接种覆盖率仍不足。30至49岁成年人中乙肝疫苗介导的免疫力较低。建议更新我国成人乙肝疫苗接种指南,取消危险因素评估和接种前血清学筛查,强调对所有未接种的成年人进行普遍接种以提高覆盖率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/198b/11488135/3ed64fcb1b69/ofae589f1.jpg

相似文献

1
Survey of Hepatitis B Vaccination Coverage and Surface Antibody-Positive Rates in People Aged 1-59 Years in 2006 and 2024.
Open Forum Infect Dis. 2024 Oct 5;11(10):ofae589. doi: 10.1093/ofid/ofae589. eCollection 2024 Oct.
2
Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China.
Front Public Health. 2023 Dec 14;11:1302183. doi: 10.3389/fpubh.2023.1302183. eCollection 2023.
3
Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.
MMWR Surveill Summ. 2017 May 5;66(11):1-28. doi: 10.15585/mmwr.ss6611a1.
4
[A cross-sectional study of seroepidemiology of viral hepatitis among Uighurs in Shufu of Xinjiang].
Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Jun 6;51(6):484-489. doi: 10.3760/cma.j.issn.0253-9624.2017.06.006.
5
Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
MMWR Surveill Summ. 2021 May 14;70(3):1-26. doi: 10.15585/mmwr.ss7003a1.
6
[Distribution of both HBsAg and HBsAb negative adults in Mianyang, Sichuan province].
Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Jan;37(1):60-3. doi: 10.3760/cma.j.issn.0254-6450.2016.01.012.
7
Adult Hepatitis B Virus Vaccination Coverage in China from 2011 to 2021: A Systematic Review.
Vaccines (Basel). 2022 Jun 6;10(6):900. doi: 10.3390/vaccines10060900.
8
Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.
MMWR Surveill Summ. 2016 Feb 5;65(1):1-36. doi: 10.15585/mmwr.ss6501a1.

引用本文的文献

1
Epidemic Trends and Spatial Distribution Characteristics of Hepatitis B in China: Surveillance Study.
JMIR Public Health Surveill. 2025 May 12;11:e70888. doi: 10.2196/70888.

本文引用的文献

1
Hepatitis B Vaccine: Four Decades on.
Vaccines (Basel). 2024 Apr 18;12(4):439. doi: 10.3390/vaccines12040439.
3
Hepatitis B.
Lancet. 2023 Mar 25;401(10381):1039-1052. doi: 10.1016/S0140-6736(22)01468-4. Epub 2023 Feb 9.
5
Adult Hepatitis B Virus Vaccination Coverage in China from 2011 to 2021: A Systematic Review.
Vaccines (Basel). 2022 Jun 6;10(6):900. doi: 10.3390/vaccines10060900.
6
Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):796-829. doi: 10.1016/S2468-1253(22)00124-8. Epub 2022 Jun 21.
8
[Study on changes in hepatitis B incidence in China, 1990-2017].
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Apr 10;42(4):613-619. doi: 10.3760/cma.j.cn112338-20201026-01281.
10
Hepatitis B Vaccines.
J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S343-S351. doi: 10.1093/infdis/jiaa668.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验